Pre-seed · Biotech
molmir raises pre-seed funding for molecular-dynamics platform
Real Tech Fund and KTX backed the company’s early drug-discovery work.
molmir Inc. has completed a pre-seed equity financing from Real Tech Fund and KTX Corporation, announced on November 24, 2022. The amount was not disclosed.
The company combines chemical-tongue sensing and nuclear magnetic resonance to examine molecular movement and states. It aims to turn those measurements into tools for drug discovery.
Funding will support research infrastructure, scientist recruitment, NMR analysis software and intellectual-property development. The company also plans to build its management team and pursue commercial partnerships.
Use of funds
Advance molecular-dynamics drug-discovery research
Funding history
Pre-seed · This roundUndisclosed